BEIJING, Feb. 29, 2024 /PRNewswire/ — A news report from chinadaily.com.cn: The World Internet Conference (WIC) held a forum on Feb 27 themed on “Computing Power Network: Smarter Network for a Smarter World” during the Mobile World Congress Barcelona 2024 in Spain. Zhuang Rongwen, chair…
Month: February 2024
A World Health Organization report highlights that a third of the global adult population suffers from hypertension, with nearly half undiagnosed due to inadequate blood pressure meters, posing significant health risks. BEIJING, Feb. 28, 2024 /PRNewswire/ — Hanvon Technology Co., Ltd.,…
TOKYO, Feb. 29, 2024 /PRNewswire/ — KLab Inc., a leader in online mobile games, announced that its hit 3D action game Bleach: Brave Souls, currently available on smartphones, PC, and PlayStation 4, has reached a total of 85 million downloads worldwide. See the original press release…
MÖLNDAL, Sweden, Feb. 29, 2024 /PRNewswire/ — THIRD QUARTER 2023/24 (NOV – JAN) Net sales amounts to 30.1 (18.7) MSEK, which is an increase of 61% compared with the corresponding period last year. The growth in the US market is 43% compared with the corresponding period last year….
GUANGZHOU, China, Feb. 29, 2024 /PRNewswire/ — ZWSOFT, a reliable provider of all-in-one CAx (CAD/CAE/CAM) solutions, is proud to announce that its flagship product, ZWCAD, has been named to G2’s 2024 Best Software Awards, ranking #14 on the CAD and PLM Product list. This prestigious…
RICHMOND, Va., Feb. 29, 2024 /PRNewswire/ — Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, today announced that its subsidiary, Indivior Inc., has received final Court approval for its settlement with the Direct Purchaser class, concluding the anti-trust…
BARCELONA, Spain and DÜSSELDORF, Germany, Feb. 29, 2024 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, and Minoryx Therapeutics, a late stage biotech company focused…
BARCELONA, Spain and DÜSSELDORF, Germany, Feb. 29, 2024 /PRNewswire/ — Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, and Minoryx Therapeutics, a late stage biotech company focused…
WILMINGTON, Mass. and OKLAHOMA CITY, Feb. 29, 2024 /PRNewswire/ — Wheeler Bio, Inc., an agile contract development and manufacturing organization (CDMO), announced today a new strategic agreement with Charles River Laboratories International, Inc. (NYSE: CRL), a global leader in pharma…
LONDON, Feb. 29, 2024 /PRNewswire/ — Tetragon has released its Monthly Factsheet for January 2024. Net Asset Value: $2,778m Fully Diluted NAV Per Share: $30.72 Share Price (TFG NA): $9.90 Monthly NAV per share total return: -1.3% Monthly Return on Equity: -1.5% Most recent quarterly…